Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TORPEDO-NL: Thrombectomy vs Thrombolysis in High-Risk PE
NCT06833827Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Feb 2025
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Composite incidence of all-cause mortality, treatment failure, major bleeding and all-cause stroke at 30 days. Started Feb 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06833827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06833827.